| Dr Marisa Wileatha Glivings, PSYD | |
|
41990 Cook St Bldg F, Palm Desert, CA 92211-6100 | |
| (707) 341-5570 | |
| Not Available |
| Full Name | Dr Marisa Wileatha Glivings |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 41990 Cook St Bldg F, Palm Desert, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548724545 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 29967 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marisa Wileatha Glivings, PSYD 2443 Fair Oaks Blvd # 117, Sacramento, CA 95825-7684 Ph: () - | Dr Marisa Wileatha Glivings, PSYD 41990 Cook St Bldg F, Palm Desert, CA 92211-6100 Ph: (707) 341-5570 |
News Archive
Somaxon Pharmaceuticals, Inc. and Paladin Labs Inc. today announced that they have entered into an exclusive collaboration under which Paladin will commercialize Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance in Canada, South America and Africa.
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the Company is the Title Sponsor of the 8th annual Working 2 Walk Science & Advocacy Symposium taking place September 27-28, 2013 at the Boston Convention & Exhibit Center in Boston, MA.
Antidepressant use in people with chronic obstructive pulmonary disease is associated with a 20 percent increase in likelihood of death and a 15 percent increase in likelihood of hospitalization due to related symptoms, finds a new study led by researchers at St. Michael's Hospital.
German researchers say they have found that long-term psychotherapy is effective and even superior to shorter-term therapy for patients with complex mental disorders such as personality and chronic mental disorders.
Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.
› Verified 3 days ago
Dr. William Harley Jones, PH. D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 45175 Panorama Dr, Suite B, Palm Desert, CA 92260 Phone: 760-346-4665 Fax: 760-776-4073 | |
Dr. Bert Meltzer, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 78432 Glastonbury Way, Palm Desert, CA 92211 Phone: 909-563-0252 | |
Miss Angela Maria Kessler, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 44530 San Carlos Ave, Palm Desert, CA 92260 Phone: 231-638-1195 | |
Leslie Haco Alhadeff, M.D., M.P.H. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 41865 Boardwalk, Suite 204, Palm Desert, CA 92211 Phone: 760-674-0331 Fax: 760-674-0332 | |
Dr. John N. Mckelvie, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 41990 Cook St, Bldg F, Suite 1002, Palm Desert, CA 92211 Phone: 760-423-1323 Fax: 760-341-5622 | |
Dr. Jana Kay Johnson, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 41865 Boardwalk, Suite 215, Palm Desert, CA 92211 Phone: 760-341-6655 Fax: 760-341-6685 | |
Dr. Daniel Loyd Watson, PH. D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 73567 Fred Waring Dr, Palm Desert, CA 92260 Phone: 760-837-1188 Fax: 760-340-1913 |